PolyPid Announces Exclusive Partnership with Azurity Pharmaceuticals for the Commercialization of D-PLEX₁₀₀ in the U.S. and Canada
Go back to PolyPid Announces Exclusive Partnership with Azurity Pharmaceuticals for the Commercialization of D-PLEX₁₀₀ in the U.S. and Canada| (NASDAQ: PYPD) | Delayed: 5.27 +0.24 (4.77%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $5.03 | 52 Week High | $ | |||
| Open | $5.06 | 52 Week Low | $ | |||
| Day High | $5.27 | P/E | N/A | |||
| Day Low | $5.06 | EPS | $ | |||
| Volume | 17,408 | |||||
